Series of blockbuster drugs to be expired in patent at the year end

At the end of this year, a series of large blockbuster drugs including an antidiabetic ‘Twynsta’ will be expired in patent, and a follow-up great war of generics is about to occur.

According to the pharmaceutical industry, starting with ‘Twynsta’ on the 18^th August, PMSs and patents of large blockbuster drugs, such as ‘Telminuvo,’ ‘Joins,’ ‘Tarceva’ and ‘Iressa’ will be expired.

It was told d...